Failure of a Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effi cacy of H. pylori Eradication in H. pylori -Infected Patients with Functional Dyspepsia
2
조회
0
다운로드
7
인용
0
참고문헌
키워드
초록
Background/Aims: The role of Helicobacter pylori eradication in patients with functional dyspepsia (FD) is still uncertain. We originally planned a randomized clinical study to observe dyspeptic symptoms after H. pylori eradication therapy. However, we failed to complete the study; therefore,we analyzed the factors that affected the failure of the study. Methods: Interviews and questionnaire surveys were conducted to analyze the factors that induced early termination from the study. Results: Many patients were screened by gastroenterologists at 11 tertiary referral hospitals between July 2009 and August 2010; however, only 4 patients met the enrollment criteria. Most patients who visited our clinics had been experiencing FD symptoms for less than 6 months or were already taking medication. They also demanded to continue taking medications and using other drugs. Only 3of the 4 patients signed informed consent. Conclusions: The application of the current Rome III criteria to FD is difficult to evaluate in Korean patients with dyspeptic symptoms because of the early medical evaluation. Most Korean patients who were diagnosed with FD by the Rome III criteria did not overcome their fear of being unable to use rescue medications during the study period.
Abstract
Background/Aims: The role of Helicobacter pylori eradication in patients with functional dyspepsia (FD) is still uncertain. We originally planned a randomized clinical study to observe dyspeptic symptoms after H. pylori eradication therapy. However, we failed to complete the study; therefore,we analyzed the factors that affected the failure of the study. Methods: Interviews and questionnaire surveys were conducted to analyze the factors that induced early termination from the study. Results: Many patients were screened by gastroenterologists at 11 tertiary referral hospitals between July 2009 and August 2010; however, only 4 patients met the enrollment criteria. Most patients who visited our clinics had been experiencing FD symptoms for less than 6 months or were already taking medication. They also demanded to continue taking medications and using other drugs. Only 3of the 4 patients signed informed consent. Conclusions: The application of the current Rome III criteria to FD is difficult to evaluate in Korean patients with dyspeptic symptoms because of the early medical evaluation. Most Korean patients who were diagnosed with FD by the Rome III criteria did not overcome their fear of being unable to use rescue medications during the study period.
참고문헌 (13)
- Mimidis K, "Pathogenesis of dyspepsia", Dig Dis, 26, pp.194~202 (2008)
- Malfertheiner P, "Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report", Gut, 56, pp.772~781 (2007)
- Fock KM, "Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection", J Gastroenterol Hepatol, 24, pp.1587~1600 (2009)
- Moayyedi P, "Eradication of Helicobacter pylori for non-ulcer dyspepsia", Cochrane Database Syst Rev, 2, pp.CD002096~ (2006)
- Drossman DA, "The functional gastrointestinal disorders and the Rome III process", Gastroenterology, 130, pp.1377~1390 (2006)
- 조유경, "기능성 소화불량증의 삶의 질에 대한 모사프리드의 효과", 대한소화기학회지, 43(3), pp.160~167 (2004), 대한소화기학회
- Holtmann G, "A placebocontrolled trial of itopride in functional dyspepsia", N Engl J Med, 354, pp.832~840 (2006)
- Tack J, "Functional gastroduodenal disorders", Gastroenterology, 130, pp.1466~1479 (2006)
- Tack J, "Prevalence of acid reflux in functional dyspepsia and its association with symptom profile", Gut, 54, pp.1370~1376 (2005)
- Kaji M, "Prevalence of overlaps between GERD, FD and IBS and impact on health-related quality of life", J Gastroenterol Hepatol, 25, pp.1151~1156 (2010)
- Young Wook Noh, "Overlap of Erosive and Non-erosive Reflux Diseases With Functional Gastrointestinal Disorders According to Rome III Criteria", Journal of Neurogastroenterology and Motility (JNM), 16(2), pp.148~156 (2010), 대한소화기 기능성질환∙운동학회
- 서검석, "Seroprevalence of Helicobacter pylori in South Korea", HELICOBACTER, 12, pp.333~340, BLACKWELL PUBLISHING
- Manabe N, "Clinical characteristics of Japanese dyspeptic patients: is the Rome III classification applicable", Scand J Gastroenterol, 45, pp.567~572 (2010)